Study Says Metabolic Pathway Might Be Potential Target to Treat IPF
Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall summarizes a study from the University of Alabama at Birmingham, which discusses a metabolic pathway that researchers believe is a promising therapeutic target to fight idiopathic pulmonary fibrosis (IPF).
This study states that lung fibrosis, including IPF, occurs from abnormal healing in the lungs after persistent injury. Based on our understanding, that injury could be an infection or illness, such as bronchitis or pneumonia. Have you ever been told your IPF is a result of an infection or illness that you contracted more than once?
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: pulmonaryfibrosisnews.com
Sorry, there were no replies found.
Log in to reply.